Kidney TransplantationTransplantsGraft RejectionTissue and Organ ProcurementGraft SurvivalImmunosuppressive AgentsTissue DonorsHeart TransplantationTransplantationTransplantation, HomologousLung TransplantationBone Marrow TransplantationOrgan TransplantationCyclosporineTacrolimusLiving DonorsWaiting ListsTime FactorsTreatment OutcomePostoperative ComplicationsImmunosuppressionRetrospective StudiesHematopoietic Stem Cell TransplantationCytomegalovirus InfectionsFetal Tissue TransplantationCadaverMultiple Organ FailureMycophenolic AcidTransplantation ImmunologyHistocompatibility TestingImmunocompromised HostLiver FailureOrgan SizeKidney Failure, ChronicGraft vs Host DiseaseOrgan SpecificityOrgan of CortiHeart-Lung TransplantationKidneyRisk FactorsTransplantation, AutologousBrain Tissue TransplantationBronchiolitis ObliteransTransplantation, HeterotopicBrain DeathTransplantation ToleranceFollow-Up StudiesHistocompatibilityCytomegalovirusOpportunistic InfectionsTransplantation ConditioningTissue and Organ HarvestingSurvival RateSurvival AnalysisRecurrenceBK VirusBiopsyHLA AntigensLiver DiseasesGanciclovirLymphoproliferative DisordersAntilymphocyte SerumProspective StudiesIsoantibodiesKidney DiseasesEnd Stage Liver DiseasePolyomavirus InfectionsTransplantation, IsogeneicCreatinineIncidenceIslets of Langerhans TransplantationHematologic NeoplasmsLiverAcute DiseaseMycosesFatal OutcomeVomeronasal OrganPostoperative PeriodMice, Inbred C57BLPrognosisAntiviral AgentsDirected Tissue DonationSubfornical OrganPrimary Graft DysfunctionStem Cell TransplantationWhole-Body IrradiationSirolimusCohort StudiesPatient SelectionTransplantation ChimeraTissue TransplantationCalcineurinInfectionPelvic Organ ProlapseRegistriesT-LymphocytesRisk AssessmentDrug Therapy, CombinationBiological MarkersCorneal Transplantation